The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Anti-Müllerian hormone plasma levels in spontaneous menstrual cycle and during treatment with FSH to induce ovulation
Open accessAbstract
BACKGROUND: Anti-Müllerian hormone (AMH) is member of the transforming growth factor-beta superfamily of growth factors. AMH is detected in serum from women of reproductive age and its levels vary slightly with the menstrual cycle, reaching the peak value in the late follicular phase. The present study was undertaken to assess the effect of controlled ovarian stimulation on AMH secretion by the ovary in healthy women in order to obtain more insight into the relationship between this peptide and gonadal steroids. METHODS: Twenty-four normally cycling women attending the infertility clinic volunteered for this study and AMH was measured in blood samples obtained during both spontaneous and FSH-treated cycles. RESULTS: AMH plasma levels did not change significantly from day 2 to day 6 in spontaneous cycles. On the contrary, AMH levels decreased progressively from day 2 to day 6 in FSH-treated cycles. A significant positive correlation was found between the decrease in AMH and the increase in estradiol plasma levels in FSH-treated cycles and between basal AMH and the peak estradiol (E2) during exogenous FSH administration. CONCLUSIONS: The present study demonstrated that AMH plasma levels did not change during the follicular phase of the menstrual cycle and that exogenous FSH administration is followed by a significant reduction in AMH levels which is probably secondary to the gonadotrophin effect on the process of follicular development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dickey, R. P., Pyrzak, R., Lu, P. Y., Taylor, S. N., & Rye, P. H. (1999) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00519-6 · Cited by 163 · cited 2×
“patients with male factor infertility if the total motile sperm count was $5 £ 10(6)/ml (Dickey et al., 1999).”
BackgroundMethod
Cited by
Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)
La Marca, A., Sighinolfi, G., Radi, D., Argento, C., Baraldi, E., Artenisio, A. C., Stabile, G., & Volpe, A. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmp036 · Cited by 956
Self-citationAnti-Müllerian hormone: a new marker for ovarian function
Visser, J. A., de Jong, F. H., Laven, J. S. E., & Themmen, A. P. N. (2006) · Reproduction · doi:10.1530/rep.1.00529 · Cited by 799
Broer, S. L., Mol, B. W. J., Hendriks, D., & Broekmans, F. J. M. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.12.013 · Cited by 546
Dewailly, D., Robin, G., Peigne, M., Decanter, C., Pigny, P., & Catteau-Jonard, S. (2016) · Human Reproduction Update · doi:10.1093/humupd/dmw027 · Cited by 526
Hehenkamp, W. J. K., Looman, C. W. N., Themmen, A. P. N., de Jong, F. H., te Velde, E. R., & Broekmans, F. J. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0331 · Cited by 509
A Validated Model of Serum Anti-Müllerian Hormone from Conception to Menopause
Kelsey, T. W., Wright, P., Nelson, S. M., Anderson, R. A., & Wallace, W. H. B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022024 · Cited by 457
Female reproductive ageing: current knowledge and future trends
Broekmans, F. J., Knauff, E. A. H., te Velde, E. R., Macklon, N. S., & Fauser, B. C. (2007) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2007.01.004 · Cited by 427
Nelson, S. M., Yates, R. W., & Fleming, R. (2007) · Human Reproduction · doi:10.1093/humrep/dem204 · Cited by 391
Serum Anti-Müllerian Hormone Levels Reflect the Size of the Primordial Follicle Pool in Mice
Kevenaar, M. E., Meerasahib, M. F., Kramer, P., van de Lang-Born, B. M. N., de Jong, F. H., Groome, N. P., Themmen, A. P. N., & Visser, J. A. (2006) · Endocrinology · doi:10.1210/en.2005-1588 · Cited by 389
La Marca, A., & Volpe, A. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02533.x · Cited by 369
Self-citationAnderson, R. A., Themmen, A. P. N., -Qahtani, A. A., Groome, N. P., & Cameron, D. A. (2006) · Human Reproduction · doi:10.1093/humrep/del201 · Cited by 365
Anti-Mullerian hormone (AMH): what do we still need to know?
La Marca, A., Broekmans, F. J., Volpe, A., Fauser, B. C., Macklon, N. S., & on behalf of the ESHRE Special Interest Group for Reproductive Endocrinology - AMH Round Table (2009) · Human Reproduction · doi:10.1093/humrep/dep210 · Cited by 327
Self-citationPreventing ovarian hyperstimulation syndrome: guidance for the clinician
Humaidan, P., Quartarolo, J., & Papanikolaou, E. G. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.03.028 · Cited by 321
Assessing ovarian response: antral follicle count versus anti-Müllerian hormone
Fleming, R., Seifer, D. B., Frattarelli, J. L., & Ruman, J. (2015) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2015.06.015 · Cited by 291
Basal level of anti-Müllerian hormone is associated with oocyte quality in stimulated cycles
Ebner, T., Sommergruber, M., Moser, M., Shebl, O., Schreier-Lechner, E., & Tews, G. (2006) · Human Reproduction · doi:10.1093/humrep/del127 · Cited by 281
Lee, T.-H., Liu, C.-H., Huang, C.-C., Wu, Y.-L., Shih, Y.-T., Ho, H.-N., Yang, Y.-S., & Lee, M.-S. (2007) · Human Reproduction · doi:10.1093/humrep/dem254 · Cited by 279
Is foetal hyperexposure to androgens a cause of PCOS?
Filippou, P., & Homburg, R. (2017) · Human Reproduction Update · doi:10.1093/humupd/dmx013 · Cited by 152
The role of AMH in the pathophysiology of polycystic ovarian syndrome
Garg, D., & Tal, R. (2016) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2016.04.007 · Cited by 150
Metadata
- Authors
- La Marca, A., Malmusi, S., Giulini, S., Tamaro, L. F., Orvieto, R., Levratti, P., & Volpe, A.
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-12-01
- Volume
- 19
- Issue
- 12
- Pages
- 2738-2741
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W2139492187
- Cited by
- 191
- References
- 1
- FWCI
- 7.43
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.